For most of its history, the US military has refused to recruit HIV-positive soldiers. The Trump administration appears to be ...

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Florida's recent decision to narrow eligibility for the Ryan White AIDS Drug Assistance Program (ADAP) is expected to limit ...

Healthcare advocates from across Florida will emerge on the state capitol to speak out against drastic cuts to Florida's AIDS Drug Assistance Program (ADAP), recently announced by the Florida ...

Rakhants’a’s mother died when he was very young, leaving his grandmother to raise him. In 2007, when he was just 4 years old, ...

The Pentagon has ordered the military command that oversees new recruits’ enlistment to hold off on initial training for ...

This study uses Population-based HIV Impact Assessments survey data to examine factors associated with gender disparities in ...

A new study offers good news from Uganda — although the cuts in U.S. aid cast a shadow over the reduction in deaths of parents from HIV/AIDS.

Advancements in HIV/AIDS research, drug development, and clinical practice since the 1980s have made it possible for people living with HIV to lead long, productive lives and keep the virus in check ...

Dec 15 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling drug Biktarvy in a late-stage ...

Around the world, some 40 million people are living with HIV. And though progress in treatment means the infection isn’t the death sentence it once was, researchers have never been able to bring about ...